Hans-Guido Wendel

Principal Investigator at the Cancer Genetics Laboratory at Memorial Sloan-Kettering Cancer Center

Dr. Hans-Guido Wendel, M.D. is a Principal Investigator at the Cancer Genetics Laboratory at Memorial Sloan-Kettering Cancer Center. He works to identify new cancer therapies based on the genetic origins of the disease. He come from Germany and trained in medicine in Aachen and Edinburgh and is currently an Associate Member of the Sloan-Kettering Institute. Special focus areas of his work are lymphatic leukemias and lymphoma and he found that the process of translation, whereby a message RNA is ‘translated’ into the effector protein, is an understudied area in cancer that holds great promise for new therapies. Conveniently, nature –in the form of various plants, marine sponges, and corals – has also found translation to be a good target and a number of natural compounds exist that target this process. Their role in cancer is largely unknown, they have never been tested clinically, and this is an area Guido’s lab is most currently excited about.

Participant In:

Cancer: Body & Mind

Saturday, October 11, 2014

Past Event

Throughout history, no other disease entity has exceeded cancer in its evocation of fear, taboo, misconceptions, and metaphors. In her 1978 book, Illness as Metaphor, Susan Sontag threw down the gauntlet in her denunciation of metaphor applied to illness, as leading to a false connection between psychological traits and disease, scorning the contemporaneous, popular notion of… read more »

The Helix Center is pleased to announce receipt of a grant from the John Templeton Foundation in support of a series of fourteen roundtables addressing big questions in the physical, natural, and biological sciences and the humanities. The topics are: Knowledge and Limitations; The Span of Infinity; Complexity and Emergence; The Search for Immortality;  The Sublime Experience; The Meditative State; The… read more »

Genes, Computers, and Medicine

Saturday, February 20, 2016
2:30-4:30 p.m.

Past Event

Developments in computational neuroscience, molecular biology, and genomics have opened up new ways of looking at disease. In a relatively short time span, these advances may lead to significant innovations in the understanding of various diseases, as well as in therapeutics designed to treat them. How might these changes affect our perceptions and experiences of… read more »